Jpmorgan Chase & CO Ventyx Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,007,519 shares of VTYX stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,007,519
Previous 987,283 2.05%
Holding current value
$1.86 Million
Previous $2.28 Million 3.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$1.85 - $3.2 $37,436 - $64,755
20,236 Added 2.05%
1,007,519 $2.2 Million
Q2 2024

Aug 12, 2024
BUY
$2.31 - $5.59 $78,101 - $188,997
33,810 Added 3.55%
987,283 $2.28 Million
Q1 2024

May 10, 2024
BUY
$1.9 - $10.13 $1.6 Million - $8.54 Million
843,101 Added 763.87%
953,473 $5.24 Million
Q4 2023

Feb 12, 2024
SELL
$2.08 - $31.18 $102,042 - $1.53 Million
-49,059 Reduced 30.77%
110,372 $272,000
Q3 2023

Nov 14, 2023
SELL
$29.8 - $40.3 $718,507 - $971,673
-24,111 Reduced 13.14%
159,431 $5.54 Million
Q2 2023

Aug 11, 2023
SELL
$28.53 - $39.55 $1.43 Million - $1.98 Million
-50,108 Reduced 21.45%
183,542 $6.02 Million
Q1 2023

May 18, 2023
BUY
$29.51 - $46.65 $563,729 - $891,154
19,103 Added 8.9%
233,650 $7.83 Million
Q1 2023

May 11, 2023
BUY
$29.51 - $46.65 $5.83 Million - $9.22 Million
197,594 Added 1165.54%
214,547 $7.19 Million
Q4 2022

Feb 13, 2023
BUY
$24.16 - $36.38 $113,672 - $171,167
4,705 Added 38.41%
16,953 $556,000
Q3 2022

Nov 14, 2022
BUY
$12.64 - $38.7 $3,336 - $10,216
264 Added 2.2%
12,248 $428,000
Q2 2022

Aug 11, 2022
BUY
$11.95 - $18.75 $52,472 - $82,331
4,391 Added 57.83%
11,984 $147,000
Q1 2022

May 11, 2022
SELL
$10.0 - $19.98 $557,170 - $1.11 Million
-55,717 Reduced 88.01%
7,593 $103,000
Q4 2021

Feb 10, 2022
BUY
$14.2 - $23.07 $899,002 - $1.46 Million
63,310 New
63,310 $1.26 Million

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $105M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email